Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Craig Mull Insider Profile
4 Followers
Craig Mull, Chairman & Interim Chief Executive, Ten Percent Owner at Cipher Pharmaceuticals, holds 10.29M shares in Cipher Pharmaceuticals (Ticker: CPHRF).
Craig Mull Cipher Pharmaceuticals (CPHRF)Chairman & Interim Chief Executive, Ten Percent Owner
Cipher Pharmaceuticals (CPHRF)
Chairman & Interim Chief Executive, Ten Percent Owner
Not Ranked
Craig Mull has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Roles
Chairman & Interim Chief Executive, Ten Percent Owner
Roles that Craig Mull holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Craig Mull
Craig Mull's Trading History
List of latest transactions for each holding click on a transaction to see Craig Mull's performance on stock
You May Also Like
Craig Mull insider profile FAQ
What is the percentage of profitable transactions made by Craig Mull?
The percentage of profitable transactions made by Craig Mull is ―.
What is the average return per transaction made by Craig Mull?
The average return per transaction made by Craig Mull is ―.
What stocks does Craig Mull hold?
Craig Mull holds: CPHRF stocks.
What was Craig Mull’s latest transaction?
Craig Mull latest transaction was an Uninformative Sell of ―.
What was Craig Mull's most profitable transaction?
Craig Mull’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Craig Mull's role in Cipher Pharmaceuticals?
Craig Mull's role in Cipher Pharmaceuticals is Chairman & Interim Chief Executive, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.